TY  - GEN
AU  - Zervas,K
AU  - Dimopoulos,M A
AU  - Hatzicharissi,E
AU  - Anagnostopoulos,A
AU  - Papaioannou,M
AU  - Mitsouli,Ch
AU  - Panagiotidis,P
AU  - Korantzis,J
AU  - Tzilianos,M
AU  - Maniatis,A
TI  - Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study
SN  - 0923-7534
PY  - 2004///0527
KW  - Adult
KW  - Aged
KW  - Ambulatory Care
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Dexamethasone
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Stem Cell Transplantation
KW  - Thalidomide
KW  - Transplantation, Autologous
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1093/annonc/mdh026
ER  -